Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

Vasohibin‐1 (VASH1) is a VEGF‐inducible endothelium‐derived angiogenesis inhibitor, and vasohibin‐2 (VASH2), its homolog, exhibits proangiogenic activity. VASH2 is expressed by various cancer cells and accelerates tumor angiogenesis and progression. VASH2 was recently shown to exhibit tubulin carbox...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Koyanagi, Takahiro, Saga, Yasushi, Takahashi, Yoshifumi, Tamura, Kohei, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Takei, Yuji, Urabe, Masashi, Mizukami, Hiroaki, Fujiwara, Hiroyuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026928/
https://ncbi.nlm.nih.gov/pubmed/33710778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3841
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia